What does Dr. Ina Vrints do?

Dr. Ina Vrints is a specialist medical practice in Hove. Private Limited, started on 15 December 2017, 1 establishment.

What is the address of Dr. Ina Vrints?

The registered office of Dr. Ina Vrints is located at Beukenlaan 32, 2540 Hove.

Is Dr. Ina Vrints still active?

Yes. According to the CBE (30 October 2026) Dr. Ina Vrints is active, legal situation “Normale toestand”, started on 15 December 2017.

Is Dr. Ina Vrints registered on Peppol?

Yes, Dr. Ina Vrints is registered on the Peppol network with ID 0208:0685953514.

What is the enterprise number of Dr. Ina Vrints?

The enterprise number of Dr. Ina Vrints is BE0685953514.

When was Dr. Ina Vrints founded?

Dr. Ina Vrints was founded on 15 December 2017.

Who are the directors of Dr. Ina Vrints?

According to the 2025 annual accounts, the directors of Dr. Ina Vrints are: Ina Vrints.

Is Dr. Ina Vrints a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 December 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Ina Vrints make in 2025?

Dr. Ina Vrints posted a profit after taxes of € 440,707 in financial year 2025.

What is the revenue of Dr. Ina Vrints?

As a small company, Dr. Ina Vrints is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 596,763.

Dr. Ina Vrints (Private Limited) - Hove - BE0685953514

Dossier Dr. Ina Vrints, printed on 30 October 2026 from databakkes.be/en/0685953514/dr-ina-vrints. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Ina Vrints from Hove, company number BE0685953514, closed financial year 2025 with a result of € 440,707 after tax. For that financial year Dr. Ina Vrints recorded a gross margin of € 596,763 and equity of € 693,458. Compared with financial year 2024, the result moved from € 490,184 to € 440,707. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 17, 2026.

What it is worth Growing

€ 693,458

▲ 174% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 440,707

▼ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 467,891

▼ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 674,858.

People and assets in 2025

Vehicles and equipment

€ 9,980

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 80,442

▼ 25% vs 2024

€ 20,275 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Taxes

€ 90,583

▼ 27% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 578,468 Gross margin 2022: € 578,468 First fiscal year in the series	€ 641,174 Gross margin 2023: € 641,174 ▲ 11% vs 2022 (€ 578,468) Favourable step	€ 739,143 Gross margin 2024: € 739,143 ▲ 15% vs 2023 (€ 641,174) Favourable step	€ 596,763 Gross margin 2025: € 596,763 ▼ 19% vs 2024 (€ 739,143) Unfavourable step	▼ 19%
Profit after taxes	€ 398,360 Profit after taxes 2022: € 398,360 First fiscal year in the series	€ 469,302 Profit after taxes 2023: € 469,302 ▲ 18% vs 2022 (€ 398,360) Favourable step	€ 490,184 Profit after taxes 2024: € 490,184 ▲ 4% vs 2023 (€ 469,302) Favourable step	€ 440,707 Profit after taxes 2025: € 440,707 ▼ 10% vs 2024 (€ 490,184) Unfavourable step	▼ 10%
Equity	€ 315,761 Equity 2022: € 315,761 First fiscal year in the series	€ 212,567 Equity 2023: € 212,567 ▼ 33% vs 2022 (€ 315,761) Unfavourable step	€ 252,750 Equity 2024: € 252,750 ▲ 19% vs 2023 (€ 212,567) Favourable step	€ 693,458 Equity 2025: € 693,458 ▲ 174% vs 2024 (€ 252,750) Favourable step	▲ 174%
Total debts	€ 1,227,991 Total debts 2022: € 1,227,991 First fiscal year in the series	€ 665,761 Total debts 2023: € 665,761 ▼ 46% vs 2022 (€ 1,227,991) Favourable step	€ 724,118 Total debts 2024: € 724,118 ▲ 9% vs 2023 (€ 665,761) Unfavourable step	€ 191,278 Total debts 2025: € 191,278 ▼ 74% vs 2024 (€ 724,118) Favourable step	▼ 74%
Cash	€ 469,826 Cash 2022: € 469,826 First fiscal year in the series	€ 98,620 Cash 2023: € 98,620 ▼ 79% vs 2022 (€ 469,826) Unfavourable step	€ 544,759 Cash 2024: € 544,759 ▲ € 446,139 vs 2023 (€ 98,620) Favourable step	€ 467,891 Cash 2025: € 467,891 ▼ 14% vs 2024 (€ 544,759) Unfavourable step	▼ 14%
Land & buildings	€ 168,072 Land & buildings 2022: € 168,072 First fiscal year in the series	€ 160,068 Land & buildings 2023: € 160,068 ▼ 5% vs 2022 (€ 168,072) Unchanged	€ 152,065 Land & buildings 2024: € 152,065 ▼ 5% vs 2023 (€ 160,068) Unchanged	€ 144,061 Land & buildings 2025: € 144,061 ▼ 5% vs 2024 (€ 152,065) Unchanged	▼ 5%
Retained profit	€ 297,161 Retained profit 2022: € 297,161 First fiscal year in the series	€ 193,967 Retained profit 2023: € 193,967 ▼ 35% vs 2022 (€ 297,161) Unfavourable step	€ 234,150 Retained profit 2024: € 234,150 ▲ 21% vs 2023 (€ 193,967) Favourable step	€ 674,858 Retained profit 2025: € 674,858 ▲ 188% vs 2024 (€ 234,150) Favourable step	▲ 188%
Dividend	€ 950,000 Dividend 2022: € 950,000 First fiscal year in the series	€ 572,496 Dividend 2023: € 572,496 ▼ 40% vs 2022 (€ 950,000) Unchanged	€ 450,000 Dividend 2024: € 450,000 ▼ 21% vs 2023 (€ 572,496) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 450,000) Unchanged	▼ 100%
Bank debt	€ 173,151 Bank debt 2022: € 173,151 First fiscal year in the series	€ 140,326 Bank debt 2023: € 140,326 ▼ 19% vs 2022 (€ 173,151) Favourable step	€ 107,196 Bank debt 2024: € 107,196 ▼ 24% vs 2023 (€ 140,326) Favourable step	€ 80,442 Bank debt 2025: € 80,442 ▼ 25% vs 2024 (€ 107,196) Favourable step	▼ 25%
Balance sheet total	€ 1,543,752 Balance sheet total 2022: € 1,543,752 First fiscal year in the series	€ 878,328 Balance sheet total 2023: € 878,328 ▼ 43% vs 2022 (€ 1,543,752) Unchanged	€ 976,868 Balance sheet total 2024: € 976,868 ▲ 11% vs 2023 (€ 878,328) Unchanged	€ 884,736 Balance sheet total 2025: € 884,736 ▼ 9% vs 2024 (€ 976,868) Unchanged	▼ 9%

Key figures of Dr. Ina Vrints, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Ina Vrints?

What happened at Dr. Ina Vrints in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 17, 2026 New annual accounts for financial year 2025: profit of € 440,707 (▼ 10% vs 2024). filed late Source: NBB ↗
2022 Ina Vrints became a director. NBB
Dec 15, 2017 New establishment in Hove. KBO
Dec 15, 2017 Start of the company according to the CBE. KBO

In short

From € 398,360 profit in 2022 to € 440,707 profit in 2025.

Paid € 662,524 in corporate taxes since 2022.

Best year ever: 2024, with € 490,184 profit.

Paid out € 2 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Ina Vrints

Dr. Ina Vrints

Clinic 12B

Behind Dr. Ina Vrints is Ina Vrints. Ina Vrints is also behind Clinic 12B.

Directors

According to the 2025 annual accounts

Ina Vrints

Director

Also active at: Clinic 12B

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Beukenlaan 32

2540 Hove

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0685.953.514
VAT number: BE 0685.953.514
Registered office: Beukenlaan 32, 2540 Hove
Names & denominations: Dr. Ina Vrints
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 December 2017
Peppol: Active · Active since 5 Oct 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗